Acta Med. 2000, 43: 23-27

https://doi.org/10.14712/18059694.2019.113

Changes of the Serum Antibiotic Levels During Open Heart Surgery (ceftazidim, ciprofloxacin, clindamycin)

Vladimír Lonskýa, Jan Dominika, Jiří Manďáka, Eugenie Pozlerováb, Miroslav Hejzlarb, Věra Lonskáb, Marie Maršíkováa, Jaroslav Kubíčeka, Marie Snítilováb

aCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Cardiosurgery, Hradec Králové, Czech Republic
bUniversity Teaching Hospital in Hradec Králové, Department of Clinical Microbiology, Hradec Králové, Czech Republic

Received November 1, 1999
Accepted March 1, 2000

References

1. Antunes PE, Bernardo JE, Eugénio L, Ferrao de Oliveira J, Antunes MJ. Mediastinitis after aorto-coronary bypass surgery. Eur J Cardio-Thorac Surg 1997; 12:443-9. <https://doi.org/10.1016/S1010-7940(97)00179-6>
2. Bellchambers J, Harris JM, Cullinan P, Gaya H, Pepper JR. A prospective study of wound infection in coronary artery surgery. Eur J Cardio-Thorac Surg 1999; 15:45-50. <https://doi.org/10.1016/S1010-7940(98)00255-3>
3. Buylaert WA, Herregods LL, Mortier EP, Bogaert MG. Cardiopulmonary bypass and the pharmacokinetics of drugs. An update. Clin Pharmacokinetics 1989; 17:10-26. <https://doi.org/10.2165/00003088-198917010-00002>
4. Casha AR, Yang L, Kay PH, Saleh M, Cooper GJ. A biochemical study of median sternotomy closure techniques. Eur J Cardio-Thorac Surg 1999; 15:365-9. <https://doi.org/10.1016/S1010-7940(99)00014-7>
5. El Gamel A, Yonan NA, Hassan R et al. Treatment of Mediastinitis: Early Modified Robicsek Closure and Pectoralis Major Advancement Flaps. Ann Thorac Surg 1998; 65:41-7. <https://doi.org/10.1016/S0003-4975(97)01063-1>
6. Fekety F, Cluff L, Sabiston D, Seidl L, Smith J, Thoburn R. A study of antibiotic prophylaxis in cardiac surgery. J Thorac Cardiovasc Surg 1969; 57:757-63.
7. Fong I, Baker C, McKee D. The value of prophylactic antibiotics in aorta-coronary bypass operations. J Thorac Cardiovasc Surg 1979; 78:908-13.
8. Geraci JE, Dale AJ, McGoon DC. Bacterial endocarditis and endarteritis following cardiac operations. Wis Med J 1963; 62:302-15.
9. Goodman J, Schaffner W, Collins H, Battersby E, Koenig M. Infection After cardiovascular surgery. N Engl J Med 1968; 278:117-23. <https://doi.org/10.1056/NEJM196801182780301>
10. Grossi EA, Culliford AT, Krieger KH et al. A survey of 77 major infections complications of median sternotomy: a review of 7949 consecutive operative procedures. Ann Thorac Surg 1985; 40:214-21. <https://doi.org/10.1016/S0003-4975(10)60030-6>
11. Heylen RM, Wilson APR, Hichens M et al. Clearance of gentamicin during cardiac surgery. J Antimicrob Chemother 1995; 35:649-55. <https://doi.org/10.1093/jac/35.5.649>
12. Ko W, Lazenby WD, Zelano JA, Isom WO, Krieger KH. Effects of shaving methods and intraoperative irrigation on supperative mediastinitis after bypass operations. Ann Thorac Surg 1992; 53:301-5. <https://doi.org/10.1016/0003-4975(92)91337-9>
13. Kollef MH, Sharpless L, Vlastnik J, Pasque Ch, Murphy D, Fraser V. The Impact of Nosocomial Infections on Patient Outcome Following Cardiac Surgery. Chest 1997; 112:666-75. <https://doi.org/10.1378/chest.112.3.666>
14. Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic operations. J Thorac Cardiovasc Surg 1992; 104:590-9.
15. Lonský V, Manďák J, Lonská V, Rozsíval V, Marková D, Kubíček J. Serum oxacilin and cephazolin levels during cardiopulmonary bypass. Perfusion 1992; 7:115-7. <https://doi.org/10.1177/026765919200700206>
16. Lonský V, Dominik J, Lonská V et al. Kinetika ceftazidimu při profylaktické aplikaci u kardiopulmonálního bypassu. Acta Medica (Hradec Králové) Suppl 1999; 42:57-9.
17. Loop FD, Lytle BW, Cosgrove DM et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity and cost of care. Ann Thorac Surg 1990; 49:179-87. <https://doi.org/10.1016/0003-4975(90)90136-T>
18. Menges T, Sablotzki A, Welters I, Wagner RM, Zickman B, Gronau S. Concentration of cefamandole in plasma and tissues of patients undergoing cardiac surgery: the influence of different cefamandole dosage. J Cardiothorac Vasc Anesth 1997; 11:565-70. <https://doi.org/10.1016/S1053-0770(97)90005-7>
19. Miglioli PA, Merlo F, Fabbri A, Padrini R. Teicoplanin concentrations in serum, pericardium, pericardial fluid and thoracic wall fat in patients undergoing cardiopulmonary bypass surgery. J Antimicrob Chemother 1997; 39:229-33. <https://doi.org/10.1093/jac/39.2.229>
20. Miglioli PA, Merlo F, Campanile F, Padrini R. Effects of cardiopulmonary bypass on teicoplanin serum disposition. Int J Clin Pharmacology Research 1995; 15:23-5.
21. Niederhäuser U, Vogt M, Vogt P, Genoni M, Künzli A, Turina MI. Cardiac surgery in a high-risk group of patients: Is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardivasc Surg 1997; 114:162-8. <https://doi.org/10.1016/S0022-5223(97)70140-5>
22. Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61:1030–6. <https://doi.org/10.1016/0003-4975(95)01035-1>
23. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Int Med 1982; 97:309-17. <https://doi.org/10.7326/0003-4819-97-3-309>
24. Wilson APR, Taylor B, Treasure T et al. Antibiotic prophalaxis in cardiac surgery: serum and tussue levels of teicoplanin, flucloxacilin and tobramycin. J Antimicrob Chemother 1988; 21:201-12. <https://doi.org/10.1093/jac/21.2.201>
25. Wilson APR, Treasure T, Gruneberg RN, Sturridge MF, Ross DN. Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacilin and tobramycin. J Antimicrob Chemother 1988; 21:213-23. <https://doi.org/10.1093/jac/21.2.213>
26. Wilson APR. Antibiotic prophylaxis in cardiac surgery. J Antimicrob Chemother 1988; 21:522-4. <https://doi.org/10.1093/jac/21.5.522>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive